Literature DB >> 31069708

Cerebrovascular events after herpes zoster infection: a risk that should be not underestimated.

Marco Zuin1, Gianluca Rigatelli2, Alessandro Adami3.   

Abstract

The occurrence of a cerebrovascular event after a herpes zoster (HZ) infection represents a nightmare in clinical practice, especially in those patients with concomitant cardiovascular comorbidities/risk factors and disease related per se to a higher risk of zoster infection. Moreover, the absence of a consensus opinion regarding a specific and adequate prevention of cerebrovascular events in these patients further complicates the treatment. Accumulating evidences demonstrated that HZ and HZ ophtalmicus (HZO) increase the risk of cerebrovascular events in the short-and long-term periods. Moreover, patient's ages < 40 years old, despite having fewer traditional cardiovascular comorbidities, demonstrated a higher risk of cerebrovascular events after both HZ and HZO infection. Further prospective studies are needed to analyse the role of antiviral treatments and vaccination in these subjects to clarify if they could be able to reduce the risk of stroke after a zoster infection. In the meanwhile, physicians must be aware of a higher risk of cerebrovascular events, especially in younger patients, with few cardiovascular risk factors, after an HZ infection.

Entities:  

Keywords:  Cerebrovascular events; Herpes zoster; Stroke

Mesh:

Substances:

Year:  2019        PMID: 31069708     DOI: 10.1007/s13365-019-00748-9

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   3.739


  35 in total

1.  Varicella zoster virus vasculopathy: analysis of virus-infected arteries.

Authors:  M A Nagel; I Traktinskiy; Y Azarkh; B Kleinschmidt-DeMasters; T Hedley-Whyte; A Russman; E M VanEgmond; K Stenmark; M Frid; R Mahalingam; M Wellish; A Choe; R Cordery-Cotter; R J Cohrs; D Gilden
Journal:  Neurology       Date:  2011-07-13       Impact factor: 9.910

2.  Correlation between herpes zoster and stroke-A case-control study.

Authors:  Hadiseh Hosamirudsari; Parisa Rashed; Farhad Afsari; Samaneh Akbarpour; Aliasghar Bagherzadeh
Journal:  J Med Virol       Date:  2018-05-25       Impact factor: 2.327

3.  Overall and Comparative Risk of Herpes Zoster With Pharmacotherapy for Inflammatory Bowel Diseases: A Nationwide Cohort Study.

Authors:  Nabeel Khan; Dhruvan Patel; Chinmay Trivedi; Yash Shah; Gary Lichtenstein; James Lewis; Yu-Xiao Yang
Journal:  Clin Gastroenterol Hepatol       Date:  2018-01-05       Impact factor: 11.382

4.  Risk of stroke and transient ischaemic attack after herpes zoster.

Authors:  S U Kwon; S-C Yun; M-C Kim; B J Kim; S H Lee; S-O Lee; S-H Choi; Y S Kim; J H Woo; S-H Kim
Journal:  Clin Microbiol Infect       Date:  2016-03-16       Impact factor: 8.067

Review 5.  Influence of age and health behaviors on stroke risk: lessons from longitudinal studies.

Authors:  Margaret Kelly-Hayes
Journal:  J Am Geriatr Soc       Date:  2010-10       Impact factor: 5.562

Review 6.  Varicella-Zoster Virus Infections.

Authors:  Don Gilden
Journal:  Continuum (Minneap Minn)       Date:  2015-12

7.  Risks of herpes zoster in patients with rheumatoid arthritis according to biologic disease-modifying therapy.

Authors:  Huifeng Yun; Fenglong Xie; Elizabeth Delzell; Lang Chen; Emily B Levitan; James D Lewis; Kenneth G Saag; Timothy Beukelman; Kevin Winthrop; John W Baddley; Jeffrey R Curtis
Journal:  Arthritis Care Res (Hoboken)       Date:  2015-05       Impact factor: 4.794

8.  Heightened risk of ischemic stroke after recent herpes zoster ophthalmicus.

Authors:  Charles Grose
Journal:  J Med Virol       Date:  2018-05-10       Impact factor: 2.327

9.  Risk of stroke following herpes zoster: a self-controlled case-series study.

Authors:  Sinéad M Langan; Caroline Minassian; Liam Smeeth; Sara L Thomas
Journal:  Clin Infect Dis       Date:  2014-04-02       Impact factor: 9.079

10.  Acute Cardiovascular Events after Herpes Zoster: A Self-Controlled Case Series Analysis in Vaccinated and Unvaccinated Older Residents of the United States.

Authors:  Caroline Minassian; Sara L Thomas; Liam Smeeth; Ian Douglas; Ruth Brauer; Sinéad M Langan
Journal:  PLoS Med       Date:  2015-12-15       Impact factor: 11.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.